Newly unearthed documents from Moderna Pharmaceuticals Covid patent application include a claim of concern about a “deliberate release of SARS coronavirus” 9 months before the official emergence of Covid-19. In addition, it turns out that Moderna may not have the legal right to even release its vaccine in the next few weeks because the company appears to be infringing on an existing patent for the core technology. Is this why Moderna’s executives are selling their stock?
To find the sources used in this episode, click here.
Learn about our new media platform project, ISE Media: https://ISE.Media
Learn how to invest in our project: https://wefunder.com/ise.media
Ben Swann takes a look at the highly unusual timeline by which Moderna Therapeutics is developing its C0-vId 19 virus vaccine. Now, 4 scientists with the NIH claim they hold partial patent rights on that vaccine and stand to make up to $150,000 per year. Meanwhile, as Moderna’s stock price continues to soar, 5 top executives have sold off $89 million dollars’ worth of shares, even as the company continues to bypass standard vaccine protocols in the development of its C0-vId v@ccine.
Support Truth in Media by visiting our sponsors:
Pulse Cellular: Use code “TRUTH” for 10% off every plan for life.
Pure VPN: Military grade VPN protection.
Brave Browser: Open source and built by a team of privacy-focused, performance-oriented pioneers of the web.